RBM39 and acute myeloid leukemia: RBM39-mediated alternative splicing is also involved in the carcinogenesis and progression of multiple cancers, including acute myeloid leukemia (AML), breast cancer, colorectal cancer and lung cancer [20, 21, 25, 27–29].